Business Context and Reporting Period
OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp.) filed this Form 8-K on February 14, 2025. The report announces the closing of a business combination with OSR Holdings Co., Ltd., a corporation organized under the laws of the Republic of Korea.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of the transaction closing rather than a financial performance statement.
Material Changes
- Corporate Status: The company has completed its merger with OSR Holdings Co., Ltd.
- Corporate Name: The registrant is now operating as OSR Holdings, Inc., having changed from Bellevue Life Sciences Acquisition Corp.
- Securities: The filing lists registered securities including Units (BLACU), Common Stock (BLAC), Redeemable Warrants (BLACW), and Rights (BLACR) on The Nasdaq Stock Market LLC.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future outlook, or detailed risk factors beyond the standard disclosure of the business combination closing. The primary event reported is the execution of the previously announced merger.
Investor Verification Checklist
- Verify the terms of the business combination with OSR Holdings Co., Ltd. in the attached press release (Exhibit 99.1).
- Confirm the trading status and ticker symbols for the new capital structure on Nasdaq.
- Review the full press release for details on the post-merger capitalization and any immediate liquidity implications.